These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31206207)

  • 1. Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.
    Puel V; Théophile H; Godard I; Raymond N; Miremont-Salamé G; Gosse P; Pépin JL; Pariente A
    Br J Clin Pharmacol; 2019 Aug; 85(8):1855-1858. PubMed ID: 31206207
    [No Abstract]   [Full Text] [Related]  

  • 2. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.
    De Filippo O; D'Ascenzo F; Raposeiras-Roubin S; Abu-Assi E; Peyracchia M; Bocchino PP; Kinnaird T; Ariza-Solé A; Liebetrau C; Manzano-Fernández S; Boccuzzi G; Henriques JPS; Templin C; Wilton SB; Omedè P; Velicki L; Xanthopoulou I; Correia L; Cerrato E; Rognoni A; Fabrizio U; Nuñez-Gil I; Iannaccone M; Montabone A; Taha S; Fujii T; Durante A; Song X; Gili S; Magnani G; Varbella F; Kawaji T; Blanco PF; Garay A; Quadri G; Alexopoulos D; Caneiro Queija B; Huczek Z; Cobas Paz R; González Juanatey JR; Cespón Fernández M; Nie SP; Muñoz Pousa I; Kawashiri MA; Gallo D; Morbiducci U; Conrotto F; Montefusco A; Dominguez-Rodriguez A; López-Cuenca A; Cequier A; Iñiguez-Romo A; Usmiani T; Rinaldi M; De Ferrari GM
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):31-42. PubMed ID: 31511896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor and Central Sleep Apnea.
    Revol B; Jullian-Desayes I; Tamisier R; Puel V; Mallaret M; Joyeux-Faure M; Pépin JL
    J Am Coll Cardiol; 2018 May; 71(20):2378-2379. PubMed ID: 29773166
    [No Abstract]   [Full Text] [Related]  

  • 4. Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.
    Sardella G; Mancone M; Stio RE; Cavallo E; Di Roma A; Colantonio R; Calcagno S
    Circulation; 2017 Aug; 136(6):602-604. PubMed ID: 28784829
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
    Zanchin T; Temperli F; Karagiannis A; Zanchin C; Räsänen M; Koskinas KC; Stortecky S; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Billinger M; Heg D; Pilgrim T; Valgimigli M; Windecker S; Räber L
    Circ Cardiovasc Interv; 2018 May; 11(5):e006132. PubMed ID: 29748219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
    Deharo P; Quilici J; Camoin-Jau L; Johnson TW; Bassez C; Bonnet G; Fernandez M; Ibrahim M; Suchon P; Verdier V; Fourcade L; Morange PE; Bonnet JL; Alessi MC; Cuisset T
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2560-2570. PubMed ID: 29268886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function.
    Ariotti S; van Leeuwen M; Brugaletta S; Leonardi S; Akkerhuis KM; Rimoldi SF; Janssens GN; Ortega-Paz L; Gianni U; van den Berge JC; Karagiannis A; Windecker S; Valgimigli M;
    J Am Coll Cardiol; 2018 Mar; 71(11):1289-1291. PubMed ID: 29544613
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.
    Franchi F; Faz GT; Rollini F; Park Y; Cho JR; Thano E; Hu J; Kureti M; Aggarwal N; Durairaj A; Been L; Zenni MM; Guzman LA; Suryadevara S; Antoun P; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1089-98. PubMed ID: 27013060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.
    Ortega-Paz L; Brugaletta S; Ariotti S; Akkerhuis KM; Karagiannis A; Windecker S; Valgimigli M;
    Circulation; 2018 Aug; 138(6):646-648. PubMed ID: 29794083
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends for and Clinical Factors Associated with Choice of Oral P2Y
    Jain N; Hunt SL; Cui H; Phadnis MA; Mahnken JD; Shireman TI; Dai J; Mehta JL; Rasu RS
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):511-521. PubMed ID: 31729588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
    Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
    EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The ISAR-REACT 5 trial: is there a winner between prasugrel and ticagrelor in acute coronary syndromes?].
    Ferlini M; Galvani M; Visconti LO
    G Ital Cardiol (Rome); 2020 Mar; 21(3):171-174. PubMed ID: 32100728
    [No Abstract]   [Full Text] [Related]  

  • 13. COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study.
    Laine M; Gaubert M; Frère C; Peyrol M; Thuny F; Yvorra S; Chelini V; Bultez B; Luigi S; Mokrani Z; Bessereau J; Toesca R; Champenois A; Dignat-George F; Paganelli F; Bonello L
    Platelets; 2015; 26(6):570-2. PubMed ID: 25275609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study.
    Fanaroff AC; Kaltenbach LA; Peterson ED; Akhter MW; Effron MB; Henry TD; Wang TY
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin withdrawal in patients treated with ticagrelor presenting with non-ST elevation myocardial infarction.
    Beigel R; Mazin I; Koifman E; Shechter M; Pres H; Shlomo N; Rosenberg N; Asher E; Matetzky S
    J Thromb Haemost; 2018 Apr; 16(4):663-669. PubMed ID: 29443445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prasugrel Versus Ticagrelor in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Kow CS; Zaihan AF; Hasan SS
    J Am Coll Cardiol; 2021 Mar; 77(11):1483-1484. PubMed ID: 33736833
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of alternative oral administrations of P2Y12-receptor inhibitors: Systematic review and meta-analysis.
    Serenelli M; Pavasini R; Vitali F; Tonet E; Bilotta F; Parodi G; Campo G
    J Thromb Haemost; 2019 Jun; 17(6):944-950. PubMed ID: 30884109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
    Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
    Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in Oral Antiplatelet Agents for the Treatment of Acute Coronary Syndromes: Clopidogrel, Prasugrel, and Ticagrelor.
    Roffman DS
    J Pharm Pract; 2016 Jun; 29(3):239-49. PubMed ID: 25660584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of morphine use on oral P2Y12 platelet inhibitors in acute myocardial infarction: Meta-analysis.
    Vaidya GN; Khan A; Ghafghazi S
    Indian Heart J; 2019; 71(2):126-135. PubMed ID: 31280824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.